J & J has been trying to sell Mentor for a few years now. But you may be right as J & J has dressed Mentor up to be sold. Reduced the fixed cost of a physical HQ when they closed Santa Barbara and they are now using a contracted sales force in private practice.
the FDA doesn't have to approve anything. They are trying to get a better offer from Galderma and if that falls through they are selling to venture capital like they did w Ortho Diagnostics. Venture capital would be a nightmare.
The target is Q3 prior to earnings to mask the false growth from Q4 '15/Q1'16.
the FDA doesn't have to approve anything. They are trying to get a better offer from Galderma and if that falls through they are selling to venture capital like they did w Ortho Diagnostics. Venture capital would be a nightmare.
The target is Q3 prior to earnings to mask the false growth from Q4 '15/Q1'16.